Monarch Capital Management Inc Pfizer Inc Transaction History

Monarch Capital Management Inc

$365 Million
Q3 2024

A detailed history of Monarch Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Monarch Capital Management Inc holds 107,230 shares of PFE stock, worth $2.85 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

107,230

Previous 106,132 1.03%

Holding current value

$2.85 Million

Previous $2.97 Million 4.51%

% of portfolio

0.85%

Previous 0.89%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$27.7 - $31.39 $30,414 - $34,466	1,098 Added 1.03%	107,230 $3.1 Million
Q2 2024 Jul 24, 2024	SELL	$25.26 - $29.6 $52,894 - $61,982	-2,094 Reduced 1.93%	106,132 $2.97 Million
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $8,129 - $9,335	-314 Reduced 0.29%	108,226 $3 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $41,102 - $53,387	-1,573 Reduced 1.43%	108,540 $3.12 Million
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $6,578 - $7,689	205 Added 0.19%	110,113 $3.65 Million
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $56,527 - $65,401	1,565 Added 1.44%	109,908 $4.03 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $9,847 - $12,820	250 Added 0.23%	108,343 $4.42 Million
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $211,839 - $276,533	-5,074 Reduced 4.48%	108,093 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $83,887 - $102,406	-1,917 Reduced 1.67%	113,167 $4.95 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $12,563 - $14,895	-270 Reduced 0.23%	115,084 $6.03 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $20,587 - $25,510	-450 Reduced 0.39%	115,354 $5.97 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $150,198 - $222,643	-3,635 Reduced 3.04%	115,804 $6.84 Million
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $24,806 - $31,865	632 Added 0.53%	119,439 $5.14 Million
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $10,772 - $12,204	-300 Reduced 0.25%	118,807 $4.65 Million
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $145,346 - $163,921	4,340 Added 3.78%	119,107 $4.32 Million
Q4 2020 Jan 26, 2021	SELL	$33.47 - $42.56 $43,845 - $55,753	-1,310 Reduced 1.13%	114,767 $4.23 Million
Q3 2020 Oct 22, 2020	SELL	$31.75 - $37.25 $22,701 - $26,633	-715 Reduced 0.61%	116,077 $4.26 Million
Q2 2020 Jul 23, 2020	SELL	$30.12 - $36.54 $195,689 - $237,400	-6,497 Reduced 5.27%	116,792 $3.82 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $14,488 - $20,700	-536 Reduced 0.43%	123,289 $4.02 Million
Q4 2019 Jan 28, 2020	BUY	$32.92 - $37.36 $67,486 - $76,588	2,050 Added 1.68%	123,825 $4.85 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $121,090 - $157,018	3,727 Added 3.16%	121,775 $4.38 Million
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $28,474 - $31,970	770 Added 0.66%	118,048 $5.11 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $60,787 - $66,785	1,621 Added 1.4%	117,278 $4.98 Million
Q4 2018 Jan 23, 2019	SELL	$38.47 - $43.86 $152,187 - $173,510	-3,956 Reduced 3.31%	115,657 $5.05 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $173,039 - $209,886	-5,020 Reduced 4.03%	119,613 $5.27 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $57,385 - $61,178	-1,740 Reduced 1.38%	124,633 $4.52 Million
Q1 2018 Apr 18, 2018	SELL	$31.91 - $37.02 $3,191 - $3,702	-100 Reduced 0.08%	126,373 $4.49 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $152,430 - $161,734	-4,583 Reduced 3.5%	126,473 $4.58 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $4.06 Million - $4.48 Million	131,056	131,056 $4.68 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.

Account

Monarch Capital Management Inc Pfizer Inc Transaction History